Such findings raise the possibility that m6A modulation might also be applied towards regulation of inflammation in AD; indeed a recent study observed that conditional knockout of METTL3 in microglia attenuated inflammation and Aβ accumulation in a mouse model based on Aβ injection [62]. Here, METTL3 is linked to Alzheimer disease.